Evaluation of the risk of heart failure with tumour necrosis factor inhibitors A large-scale meta-analysis in immune-mediated inflammatory diseases /
Current therapeutic guidelines for immune-mediated inflammatory diseases (IMIDs) contraindicate the administration of tumour necrosis factor inhibitors (TNFis) in advanced heart failure (HF) and highlight the potential risk for new-onset HF. The current evidence has low certainty, and the results of...
Elmentve itt :
Szerzők: |
Galajda Noémi Ágnes Meznerics Fanni Adél Mátrai Péter Fazekas Alíz Lengyel Anna Sára Kolonics Mária Veronika Kemény Lajos Vince Csupor Dezső Hegyi Péter Holló Péter Bánvölgyi András |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2025
|
Sorozat: | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
|
Tárgyszavak: | |
doi: | 10.1111/jdv.20786 |
mtmt: | 36189735 |
Online Access: | http://publicatio.bibl.u-szeged.hu/36977 |
Hasonló tételek
-
Reducing cardiovascular risk in immune‐mediated inflammatory diseases Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis /
Szerző: Galajda Noémi Ágnes, et al.
Megjelent: (2024) -
Effect of ivabradine in heart failure a meta-analysis of heart failure patients with reduced versus preserved ejection fraction /
Szerző: Tóth Noémi, et al.
Megjelent: (2021) -
Heart Failure 2019
Szerző: Gatzov Plamen, et al.
Megjelent: (2020) -
Risk factors and prevention of anthracycline-related heart failure
Szerző: Fogarassy György
Megjelent: (2020) -
The effectiveness of Fuzi in combination with routine heart failure treatment on chronic heart failure patients
Szerző: Tai Chi-Jung, et al.
Megjelent: (2022)